Literature DB >> 29339632

Identification of Rifampicin Resistance Mutations in Escherichia coli, Including an Unusual Deletion Mutation.

Eugene Y Wu1, Angela K Hilliker.   

Abstract

Rifampicin is an effective antibiotic against mycobacterial and other bacterial infections, but resistance readily emerges in laboratory and clinical settings. We screened Escherichia coli for rifampicin resistance and identified numerous mutations to the gene encoding the β-chain of RNA polymerase (rpoB), including an unusual 9-nucleotide deletion mutation. Structural modeling of the deletion mutant indicates locations of potential steric clashes with rifampicin. Sequence conservation in the region near the deletion mutation suggests a similar mutation may also confer resistance during the treatment of tuberculosis.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  <italic>Escherichia coli</italic>; Antibiotic; Mutation; Rifampicin

Mesh:

Substances:

Year:  2018        PMID: 29339632     DOI: 10.1159/000484246

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  3 in total

1.  Phenotypic and genomic comparison of Photorhabdus luminescens subsp. laumondii TT01 and a widely used rifampicin-resistant Photorhabdus luminescens laboratory strain.

Authors:  Maria-Antonia Zamora-Lagos; Simone Eckstein; Angela Langer; Athanasios Gazanis; Friedhelm Pfeiffer; Bianca Habermann; Ralf Heermann
Journal:  BMC Genomics       Date:  2018-11-29       Impact factor: 3.969

2.  Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin Due to RNA Polymerase H451D/Y/R Mutations From Computational Perspective.

Authors:  Qianqian Zhang; Xiaoli An; Hongli Liu; Shuo Wang; Tong Xiao; Huanxiang Liu
Journal:  Front Chem       Date:  2019-12-03       Impact factor: 5.221

3.  Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.

Authors:  Marcus Hong; Hissa Al-Farsi; Anna Olsson; Christian G Giske; Pernilla Lagerbäck; Thomas Tängdén
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.